Newsroom

Bakterien der Art Pseudomonas aeruginosa sind äußerst widerstandfähig und kommen fast überall vor.
News
Scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have developed a strategy to administer antibacterial agents in a way that makes them many times more effective. Their results give rise to hope in the fight against hospital infections and antibiotic resistance. The study has been published in the international edition of the journal Angewandte Chemie/Applied Chemistry. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig in cooperation with Saarland University.
17.04.2020
Viruszellen
News
The GSI Helmholtzzentrum für Schwerionenforschung and the FAIR GmbH (GSI/FAIR) uses its research potential and unique infrastructure to contribute to the management of the current corona pandemic. In several areas at GSI/FAIR, scientists are working to provide new insights and technologies that may help to fight the corona virus SARS-CoV-2. In cooperation with the Helmholtz Centre for Infection Research (HZI) in Braunschweig, methods for virus inactivation are being tested. These inactivated viruses are used for vaccine development. To this aim, the accelerators and laboratories on the Darmstadt campus are also being used. The laboratory is operational, while strictly abiding to safety regulations.
16.04.2020
Abbildung eines Corona-Virus
News
Researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Forschungszentrum Jülich (FZJ) are modelling the further course of the epidemic, taking into account various scenarios for relaxing the ban on contact and making recommendations.
14.04.2020
Coronavirus
News
Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig are simulating the effect of various conditions on the development of the SARS-CoV-2 epidemic in Germany. Their results suggest that the restrictions in social life are effective and that a further slowing of the spread is possible. In order to protect the health system from overload, they urgently warn against easing the restrictions already now. They have published their preliminary results, which have not yet been peer-reviewed, on a preprint server for quick scientific use.
08.04.2020
Viren
News
An interdisciplinary group of renowned scientists - among them Prof Gérard Krause, head of the Department Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig - is now calling for the current restrictions in society and the economy to be gradually eased, while ensuring medical care for the entire population.
04.04.2020
Die SORMAS-App in der Anwendung.
News
The Covid-19 pandemic affects more and more countries worldwide. Since the virus causes no or only mild symptoms in many infected people, researchers assume that the number of unreported cases is high. In order to slow down the further spread of the virus, health authorities are focusing on consistent management of contact persons of confirmed cases of infection. For this purpose, the German Public Health Service (ÖGD) will be able to use a special version of the SORMAS disease control app in the future.
01.04.2020

HZI in the media

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025
|
Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025
|
World Today News

Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

19.09.2025
|
Verband Deutscher Biologen e.V.

purposes.

 

Researchers at the HIRI, a site of the Braunschweig Helmholtz Center for Infection Research (HZI), in cooperation with the Julius

19.09.2025
|
NewsBreak

... ihr Team vom Helmholtz-Institut für One Health (HIOH) in Greifswald – einem Standort des Helmholtz-Zentrums ...

18.09.2025
|
Management & Krankenhaus

... der TU Braunschweig, dem Braunschweig Integrated Centre of Systems Biology (BRICS) und dem Helmholtz-Zentrum für ...

15.09.2025
|
DeutschesGesundheitsPortal

Das Institut ist ein Teil des rennommierten Helmholtz-Zentrums für Infektionsforschung ...

11.09.2025
|
NDR Norddeutscher Rundfunk

... gearbeitet werden soll. Greifswald (dpa/mv) - In einem eigenen Gebäude sollen Forscher des Helmholtz-Instituts ...

11.09.2025
|
n-tv

Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einem Standort des Braunschweiger Helmholtz- ...

11.09.2025
|
MTA Dialog

Studie und Hersteller des Prüfpräparats. Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) war bei ...

11.09.2025
|
Kölner News Journal

at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute of Molecular Infection Biology (IMIB) in Würzburg has

10.09.2025
|
Phys.org

Leiter der Abteilung Chemische Biologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig www.helmholtz-hzi.de ...

10.09.2025
|
BR Bayerischer Rundfunk

Register now for the HZI-Newsletter